SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079974-18-000540
Filing Date
2018-10-02
Accepted
2018-10-02 09:46:03
Documents
41
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 apothica10q_7312018.htm 10-Q 492520
2 ex311.htm EX-31.1 13465
3 ex321.htm EX-32.1 9494
  Complete submission text file 0001079974-18-000540.txt   1843403

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pcfp-20180731.xml EX-101.INS 218814
5 XBRL TAXONOMY EXTENSION SCHEMA pcfp-20180731.xsd EX-101.SCH 20859
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pcfp-20180731_cal.xml EX-101.CAL 25414
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pcfp-20180731_def.xml EX-101.DEF 90381
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcfp-20180731_lab.xml EX-101.LAB 108693
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcfp-20180731_pre.xml EX-101.PRE 126055
Mailing Address 10901 ROOSEVELT BLVD., SUITE 1000C SAINT PETERSBURG FL 33716
Business Address 10901 ROOSEVELT BLVD., SUITE 1000C SAINT PETERSBURG FL 33716 727-228-3994
Apotheca Biosciences, Inc. (Filer) CIK: 0001632053 (see all company filings)

IRS No.: 472055848 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 000-55467 | Film No.: 181099642
SIC: 1000 Metal Mining
Assistant Director 9